Core Viewpoint - The new strategic investment regulations create favorable conditions for both Chinese companies going abroad and foreign companies entering China, enhancing cross-border mergers and acquisitions [1] Group 1: Strategic Investment Regulations - The new regulations, titled "Management Measures for Strategic Investment by Foreign Investors in Listed Companies," facilitate cross-border equity swaps, making it easier for Chinese companies to engage in deeper cross-border industrial cooperation [1] - The implementation of the new regulations is expected to benefit Chinese companies in finding foreign partners for joint acquisitions and developments, allowing foreign partners to gain liquidity through equity swaps at the listed company level [1] Group 2: Cross-Border M&A Trends - Historically, the company's M&A business has been evenly split between domestic and cross-border transactions, with cash being the primary payment method for cross-border projects [1] - The shift towards more convenient cross-border equity swaps is anticipated to enhance the attractiveness of cross-border collaborations for Chinese enterprises [1]

Core Insights - The Shanghai Stock Exchange International Investor Conference was held on November 12-13, highlighting new favorable conditions for both Chinese companies going abroad and foreign companies entering China due to the new strategic investment regulations [1] Group 1: Strategic Investment Regulations - The new strategic investment regulations ("Management Measures for Foreign Investors' Strategic Investment in Listed Companies") create more favorable conditions for cross-border investments [1] - The implementation of the new regulations facilitates cross-border share swaps, enhancing deeper cross-border industrial cooperation for Chinese companies [1] Group 2: M&A Business Insights - The head of the M&A business at CICC, Chen Jie, noted that historically, the firm's M&A business was split evenly between domestic and cross-border projects, with cash being the primary payment method for cross-border deals [1] - The new regulations allow foreign partners to participate in joint acquisitions and developments, enabling them to convert equity into liquidity at the listed company level, which is beneficial for Chinese companies seeking foreign partners [1]

Core Insights - The three major stock indices experienced a slight decline on November 12, with the pharmaceutical sector showing strength, particularly with stocks like Yaoyigou hitting the daily limit and Jianfa Zhixin rising over 10% [2] Industry Summary - The National Disease Control and Prevention Administration held a press conference on November 10 regarding the prevention and control of acute respiratory infectious diseases during the autumn and winter seasons. Monitoring data indicates that flu activity in China is currently on the rise, with the H3N2 subtype accounting for over 95% of cases [2] - The China Securities Journal reports that the trend of innovation going global is clear, with the pharmaceutical sector leading the way. The ongoing reform in drug review processes is yielding benefits, and the Chinese innovative drug industry has entered a 2.0 era, shifting from "import imitation" to "innovation output" [2] - The report highlights that the development of innovative drugs is supported by improved investment and financing data, indicating a new cycle for CXO and upstream sectors. The potential for medical devices and other categories to also expand internationally is promising [2]

Core Viewpoint - The company plans to hold a performance briefing for the third quarter of 2025 to provide investors with a comprehensive understanding of its performance and operational status [1] Group 1 - The performance briefing is scheduled for November 21, 2025, from 16:00 to 17:00 [1] - The event will take place at the Shanghai Roadshow Center in an interactive online format [1] - The briefing aims to address common concerns from investors within the scope of information disclosure [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 China International Capital Corporation Limited 海外監管公告 本公告乃根據香港聯合交易所有限公司證券上市規則第13.10B條而作出。 茲載列中國國際金融股份有限公司（「本公司」）在上海證券交易所網站刊登的本公司關於 召開2025年第三季度業績說明會的公告，僅供參閱。 中 國 國 際 金 融 股 份 有 限 公 司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：03908） 承董事會命 中國國際金融股份有限公司 董事會秘書 孫男 中國，北京 2025年11月12日 於本公告日期，本公司執行董事為陳亮先生及王曙光先生；非執行董事為張薇女士、 孔令岩先生及田汀女士；以及獨立非執行董事為吳港平先生、陸正飛先生、彼得•諾蘭先 生及周禹先生。 证券代码：601995 证券简称：中金公司 公告编号：临 2025-038 中国国际金融股份有限公司 关于召开 20 ...

证券代码：601995 证券简称：中金公司 公告编号：临 2025-038 中国国际金融股份有限公司 关于召开 2025 年第三季度业绩说明会的公告 中国国际金融股份有限公司董事会及全体董事保证本公告内容不存在任何虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 预征集提问安排：投资者可于 2025 年 11 月 14 日（星期五）至 11 月 20 日（星期四）16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通 过公司邮箱 investorrelations@cicc.com.cn 进行提问 召开时间：2025 年 11 月 21 日（星期五）16:00-17:00 召开地点：上海证券交易所上证路演中心（roadshow.sseinfo.com） 召开方式：网络互动 三、投资者参加方式 （一）投资者可在 2025 年 11 月 21 日（星期五）16:00-17:00，通过登录上 证路演中心网站在线参与本次业绩说明会。 中国国际金融股份有限公司（以下简称"公司"）已在上海证券交易所网站 （www.sse.com.cn）披露了《2025 年第三 ...

Core Viewpoint - The integration of technology, industry, and finance is essential for technology companies to grow, generate solid profits, and maintain stable cash flows, attracting long-term patient capital [1] Group 1: Technology and Industry Integration - Connecting technology, industry, and finance can help technology companies become stronger and more profitable [1] - Long-term patient capital is crucial for the growth of technology firms, as it focuses on sustainable returns [1] Group 2: Market Dynamics - A market filled with long-term patient capital can reduce volatility caused by short-term speculation, leading to a stable environment conducive to innovation [1] - The capital market can continuously empower the long-term development of the country's new productive forces, providing ongoing momentum [1]

Core Viewpoint - The 2025 Annual Investment Strategy Conference hosted by CICC is themed "Ride the Momentum, Seek New Opportunities," gathering over 500 executives from listed companies and numerous experts from government, industry, and academia for in-depth discussions on various emerging themes [1]. Group 1: Conference Overview - The conference takes place from November 12 to 14, featuring a total theme day on the first day and ten thematic sub-forums over the following two days [1]. - Key discussion topics include new supply, new technology, new consumption, new finance, new intelligent driving, new medicine, new applications, new materials, and new energy [1]. Group 2: Key Participants - Notable speakers include Wang Shuguang, Vice Chairman and President of CICC [3], Liu Shijun, Chief Advisor of the China Council for International Cooperation on Environment and Development [5], Dr. Teh Kok Peng, Chairman of the East Asian Institute at National University of Singapore [7], Peng Wensheng, Chief Economist and Head of Research at CICC [8], and Miao Yanliang, Executive Head of the Research Department at CICC [9].

Group 1 - The Shanghai Stock Exchange International Investor Conference was held on November 12, focusing on "Value Leading, Open Empowerment - New Opportunities for International Capital Investment and M&A" [3] - The conference aimed to create a communication platform for foreign institutional investors, regulatory agencies, exchanges, listed companies, and financial institutions, promoting deep integration of international capital with the Chinese capital market [3] - Zhang Yiming from CICC highlighted the successful completion of CATL's Hong Kong IPO in May, raising $5.3 billion, showcasing international investors' recognition of high-quality Chinese technology and production assets [3][4] Group 2 - Zhang emphasized that patient capital is crucial for driving technological innovation, as long-term investments can stabilize market expectations and provide continuous momentum for new productive forces [4] - He outlined three key experiences: leveraging the synergy of investment, banking, and research to support early-stage tech companies; breaking down barriers in financial sub-industries; and ensuring smooth exit mechanisms for long-term capital [4] - Zhang noted that the global tech sector has shown a pattern of "synchronous resonance and alternating peaks," driven by breakthroughs in AI technology, which have led to record capital expenditures by tech giants [4] Group 3 - The future strategy for CICC includes deepening the "bringing in" and "going out" approach, utilizing capital market strengths to support high-quality Chinese enterprises in global expansion and providing ongoing financial support for technological innovation [5]

Core Viewpoint - The report highlights the recent trading performance and financial metrics of China International Capital Corporation (CICC), indicating a significant increase in net profit and a high level of financing balance, suggesting strong investor interest and market positioning [1][3]. Financing Performance - On November 11, CICC experienced a financing buy-in of 137 million yuan, with a net financing buy of 5.32 million yuan, while the total financing balance reached 29.41 billion yuan, accounting for 2.81% of the circulating market value [1]. - The financing balance is noted to be above the 90th percentile of the past year, indicating a high level of activity [1]. Securities Lending - On the same day, CICC repaid 3,800 shares in securities lending and sold 8,000 shares, with the selling amount calculated at 286,200 yuan [1]. - The remaining securities lending balance was 128.45 million yuan, which is below the 40th percentile of the past year, indicating a relatively low level of short selling [1]. Company Overview - CICC, established on July 31, 1995, and listed on November 2, 2020, operates in various sectors including investment banking, equity sales and trading, fixed income, commodities, wealth management, and investment management [2]. - The revenue composition shows wealth management contributing 32.58%, equity business 25.78%, fixed income 13.38%, investment banking 11.26%, and other segments making up the remainder [2]. Shareholder and Profit Metrics - As of September 30, CICC had 118,900 shareholders, a decrease of 4.10%, while the average circulating shares per person increased by 4.28% to 24,662 shares [3]. - For the first nine months of 2025, CICC reported a net profit of 6.567 billion yuan, marking a year-on-year increase of 129.75% [3]. Dividend Distribution - CICC has distributed a total of 4.924 billion yuan in dividends since its A-share listing, with 2.607 billion yuan distributed over the past three years [4]. Institutional Holdings - As of September 30, 2025, major institutional shareholders include Hong Kong Central Clearing Limited, which increased its holdings by 51.425 million shares, and several ETFs with varying changes in their holdings [4].